Consent Form - Maternal Cancer Diagnosis

Oct 23, 2015 by Elyce Cardonick Category: Forms 0 comments

Taking too long?

Reload document

Open in new tab

Download [2.14 MB]

Previous post Next post

The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment

Elyce Cardonick, Farhana Irfan, Natalie Torres ABSTRACT Intr...

Oct 20, 2015 / 0 comments
Is Pregnancy Safe after Cancer?

For many cancer survivors – both men and women alike – s...

Apr 02, 2018 / 0 comments
Clinical Research – After Chemotherapy Treatment for Maternal Cancer During Pregnancy, Is Breastfeeding Possible?

Aug 12, 2019 / 0 comments

Elyce H. Cardonick, MD, FACOG

Board Certification(s): Obstetrics and Gynecology, Maternal and Fetal Medicine
Office Location(s): Burlington, Camden, Pomona, Princeton, Sewell, Voorhees
Medical Group: Cooper University Physician

View Dr. Cardonick's complete profile >

Our Mission

Researching pregnant women with cancer and their children. By pooling information into a central registry we can accumulate stronger data to help oncologists, obstetricians and patients make informed decisions about treating cancer in pregnancy.

The Cancer and Pregnancy Fund of the Cooper Foundation is a 501(c)(3) nonprofit organization.

Follow:

Related Posts

The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment

Is Pregnancy Safe after Cancer?

Clinical Research – After Chemotherapy Treatment for Maternal Cancer During Pregnancy, Is Breastfeeding Possible?

Leave a Comment! Cancel reply

Follow Us

Contact Information:

Recent Posts

Categories

SEARCH

Tags

Elyce H. Cardonick, MD, FACOG

Our Mission